Vimarsana
Biggest News Aggregation in the World

Page 45 - Industry Classification Benchmark News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Industry Classification Benchmark. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Industry Classification Benchmark Today - Breaking & Trending Today

Get Nasdaq 100 Exposure Without Technology With This ETF - Vimarsana News

Get Nasdaq 100 Exposure Without Technology With This ETF

Investing in the Nasdaq 100 doesn't mean investors are only relegated to getting tech exposure.

ADX, FTSE Russell to launch blue chip equities index - Vimarsana News

ADX, FTSE Russell to launch blue chip equities index

The Abu Dhabi Securities Exchange (ADX) and FTSE Russell have partnered to develop the FTSE ADX 15 Index, a benchmark blue chip measure that will support ADX’s recently launched derivatives market.

ADX, FTSE Russell To Launch Benchmark Blue Chip Equities Index #AbuDhabi - Vimarsana News

ADX, FTSE Russell To Launch Benchmark Blue Chip Equities Index #AbuDhabi

ADX, FTSE Russell To Launch Benchmark Blue Chip Equities Index, News, Abu Dhabi City Guide

Lincoln National Corp Grows Position in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) - Vimarsana News

Lincoln National Corp Grows Position in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Lincoln National Corp boosted its stake in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB – Get Rating) by 4.8% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 7,172 shares of the financial services provider’s stock after purchasing an additional 326 shares during the quarter. Lincoln National […]

Concord Wealth Partners Has $43,000 Holdings in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) - Vimarsana News

Concord Wealth Partners Has $43,000 Holdings in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Concord Wealth Partners lifted its holdings in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB – Get Rating) by 313.0% in the 4th quarter, Holdings Channel reports. The firm owned 285 shares of the financial services provider’s stock after buying an additional 216 shares during the quarter. Concord Wealth Partners’ holdings in iShares Nasdaq Biotechnology ETF were worth […]